Alkermes Plc (ALKS)
33.94
+0.10
(+0.28%)
USD |
NASDAQ |
Jan 22, 16:00
33.83
-0.12
(-0.34%)
After-Hours: 18:43
Alkermes Research and Development Expense (TTM): 283.30M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | 39.89M |
| CorMedix, Inc. | 12.46M |
| Amicus Therapeutics, Inc. | 142.29M |
| Jazz Pharmaceuticals Plc | 809.33M |
| Amarin Corp. Plc | 17.36M |